AwardTape · Defense awards · Medical · Drugs and biologicals · HT001424A0002
HT001424A0002: $0 blanket purchase agreement to Sofie Co
Sofie Co holds a blanket purchase agreement from Defense Health Agency with $0 obligated since Oct 2023, against a ceiling of $1.5M. Latest action Dec 23, 2025.
Master blanket purchase agreement for pharmaceutical supplies.
| PIID | HT001424A0002 |
|---|---|
| Type | blanket purchase agreement |
| Company | Sofie Co |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $1.5M |
| Base date | Feb 22, 2024 |
| Latest action | Dec 23, 2025 |
| End date | n/a |
| Actions since Oct 2023 | 5 |
| Pricing | Set per order |
| Competition | Not reported |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Orders under this award21 orders · search
| Award | Company | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|---|
| HT001426FE014 BPA call | Sofie Co | $250K | Bpa call order for radioactive pharmaceuticals required for positron emission tomography (pet). | Defense Health Agency | Drugs and biologicals | Jan 7, 2026 DoD 90d |
| HT001424F0057 BPA call | Sofie Co | $249K | Life molecular imaging product neurace | Defense Health Agency | Drugs and biologicals | May 15, 2024 DoD 90d |
| HT001424F0118 BPA call | Sofie Co | $249K | Life molecular imaging product | Defense Health Agency | Drugs and biologicals | Jul 26, 2024 DoD 90d |
| HT001425F0019 BPA call | Sofie Co | $249K | Radiopharmaceuticals | Defense Health Agency | Drugs and biologicals | Jan 15, 2025 DoD 90d |
| HT001425F0044 BPA call | Sofie Co | $249K | Neuraceq radiopharmaceutical for positron emission tomography scans | Defense Health Agency | Drugs and biologicals | May 1, 2025 DoD 90d |
| HT001425F0050 BPA call | Sofie Co | $246K | Pylarify f 18 injection for pet scan imaging of the prostate. | Defense Health Agency | Drugs and biologicals | Apr 18, 2025 DoD 90d |
| HT001426FE062 BPA call | Sofie Co | $245K | Acquisition of neuraceq (florbetaben f18). | Defense Health Agency | Drugs and biologicals | Jun 4, 2026 DoD 90d |
| HT009025FG0610064 BPA call | Sofie Co | $44K | Radio-pharmaceuticals | Defense Health Agency | Drugs and biologicals | May 27, 2025 DoD 90d |
| HT009025FG081100 BPA call | Sofie Co | $44K | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment sofie (s0f-neuraceq) | Defense Health Agency | Drugs and biologicals | Jul 23, 2025 DoD 90d |
| HT009024FG0910085 BPA call | Sofie Co | $36K | Radiopharmaceutical. | Defense Health Agency | Drugs and biologicals | Sep 9, 2024 DoD 90d |
| HT009026FG1110036 BPA call | Sofie Co | $36K | Pharmaceuticals needed for patient care. | Defense Health Agency | Drugs and biologicals | Nov 4, 2025 DoD 90d |
| HT009025FG0310056 BPA call | Sofie Co | $29K | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment | Defense Health Agency | Health care services | Mar 20, 2025 DoD 90d |
| HT009025FG0310051 BPA call | Sofie Co | $25K | "radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment. | Defense Health Agency | Drugs and biologicals | Mar 5, 2025 DoD 90d |
| HT009025FG1210047 BPA call | Sofie Co | $25K | Radiopharmaceutical needed for prostate cancer patients with metastatic lesions after definite treatment | Defense Health Agency | Drugs and biologicals | Dec 19, 2024 DoD 90d |
| HT009026FG1210062 BPA call | Sofie Co | $25K | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment | Defense Health Agency | Instruments and lab equipment | Dec 2, 2025 DoD 90d |
| HT009026FG0210049 BPA call | Sofie Co | $22K | Radio-pharmaceutical for patient care. | Defense Health Agency | Drugs and biologicals | Feb 4, 2026 DoD 90d |
| HT009025FG0210044 BPA call | Sofie Co | $22K | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment | Defense Health Agency | Drugs and biologicals | Feb 10, 2025 DoD 90d |
| HT009025FG0710073 BPA call | Sofie Co | $14K | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment | Defense Health Agency | Health care services | Jun 24, 2025 DoD 90d |
| HT009025FG0820120 BPA call | Sofie Co | $14K | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definite treatment | Defense Health Agency | Health care services | Aug 20, 2025 DoD 90d |
| HT009024FG0510042 BPA call | Sofie Co | $11K | Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment | Defense Health Agency | Drugs and biologicals | May 9, 2024 DoD 90d |
| HT009026FG0110043 BPA call | Sofie Co | $11K | Radiopharmaceutical needed for prostate cancer patient. | Defense Health Agency | Drugs and biologicals | Dec 26, 2025 DoD 90d |
About this record
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial